Creating an effective therapeutic does not end with the identification of a compound with high activity and specificity against a protein target. The pharmaceutical needs a delivery vehicle that safely and efficiently treats the disease within a patient. Identifying the right solid form of the drug, in terms of different polymorphs or crystal morphology can significantly decrease the time required to develop the final product formulation and avoid costly late-stage project failures. In short, modeling & simulation can help to guide development efforts, minimizing risk and supporting IP capture.
BIOVIA Materials Studio: Supporting Pharmaceutical Development
BIOVIA Materials Studio provides a comprehensive suite of methods to model the behavior of drug compounds in silico.